About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Odiparcil For The Prevention Of Venous Thromboembolism

Odiparcil For The Prevention Of Venous Thromboembolism

NCT00244725·101 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

GlaxoSmithKline

Age

35–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Women must be unable to have children.
Will have a total knee replacement.

You may not be if

Allergic to any X-ray dye.
Allergies or reactions to warfarin or coumadin.
Previous VTE (venous thromboembolism) or deep vein thrombosis (DVT).
On anticoagulation therapy.
Renal impairment.
Participated in any clinical trial in the past 30 days.

The record

StatusCompleted

PhasePhase 2

Taking part961

StartedSep 2005

UpdatedMay 2, 2017

Conditions

Deep Vein Thrombosis Fibrillation, Atrial Venous Thromboembolism Pulmonary Embolism

Where101

GSK Investigational Site
Birmingham, Alabama, United States
GSK Investigational Site
Mobile, Alabama, United States
GSK Investigational Site
Phoenix, Arizona, United States